| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.097 | 0.008 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.008 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.009 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.44 | 0.009 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.01 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.13 | 0.02 |